Company
Tempus AI ($TEM)
- Funding:
- $250M · Secondary · Sep 2025
Description
AI-driven precision medicine over clinical and molecular data. Public via $TEM (NASDAQ). Chicago HQ.
Related
Monolithic Power Systems ($MPWR)Power-management semiconductors for AI servers, data centers, robotics, and industrial electronics. Public via $MPWR (NASDAQ).
WhiteLab GenomicsBuilds AI-driven platforms that predict optimal molecular constructs for genomic medicine; used by drug developers and research partners to…
Cognex ($CGNX)Machine vision, barcode readers, and AI inspection systems for factory automation and logistics. Public via $CGNX (NASDAQ). Natick MA HQ.
Legend Biotech ($LEGN)CAR-T cell therapy company behind ciltacabtagene autoleucel and next-generation cell-therapy programs. Public via $LEGN (NASDAQ).
Iambic TherapeuticsBuilds AI-driven drug discovery technologies and experimental platforms to design molecular candidates and generate biological data for…
Cadence Design Systems ($CDNS)EDA software, simulation, verification, and IP platforms for AI-chip and advanced-system design. Public via $CDNS (NASDAQ). San Jose CA HQ.
Solid Power ($SLDP)Sulfide-based solid-state battery cells and electrolyte manufacturing for electric vehicles. Public via $SLDP (NASDAQ). Louisville CO HQ.
Seagate Technology ($STX)Mass-capacity hard-drive storage for AI datasets, model archives, and hyperscale data-center infrastructure. Public via $STX (NASDAQ).
Qualcomm ($QCOM)Edge-AI processors, modem platforms, robotics chips, and automotive compute systems. Public via $QCOM (NASDAQ). San Diego CA HQ.
THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…
Genesis TherapeuticsBuilds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and…
Molecule.oneBuilds an AI-driven chemistry platform that integrates AI, lab automation, and data to enable near-autonomous research for drug discovery…
Timeline
secondary · $250M · led by SoftBankbloomberg.com ↗